Literature DB >> 8929462

CagA and the outcome of Helicobacter pylori infection.

M J Blaser, J E Crabtree.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8929462     DOI： 10.1093/ajcp/106.5.565

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN： 0002-9173            Impact factor:   2.493


× No keyword cloud information.
  11 in total

1.  CagA-dependent downregulation of B7-H2 expression on gastric mucosa and inhibition of Th17 responses during Helicobacter pylori infection.

Authors:  Taslima T Lina; Irina V Pinchuk; Jennifer House; Yoshio Yamaoka; David Y Graham; Ellen J Beswick; Victor E Reyes
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

2.  Ecology of Helicobacter pylori in the human stomach.

Authors:  M J Blaser
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

3.  Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin.

Authors:  M Gerhard; N Lehn; N Neumayer; T Borén; R Rad; W Schepp; S Miehlke; M Classen; C Prinz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  The significance of cagA(+) Helicobacter pylori in reflux oesophagitis.

Authors:  V J Warburton-Timms; A Charlett; R M Valori; J S Uff; N A Shepherd; H Barr; C A McNulty
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

5.  Analysis of serum antibody profile against H pylori VacA and CagA antigens in Turkish patients with duodenal ulcer.

Authors:  Yusuf Erzin; Sibel Altun; Ahmet Dobrucali; Mustafa Aslan; Sibel Erdamar; Ahmet Dirican; Murat Tuncer; Bekir Kocazeybek
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

6.  Serologic response to lower-molecular-weight proteins of H. pylori is related to clinical outcome of H. pylori infection in Taiwan.

Authors:  S C Shiesh; B S Sheu; H B Yang; H J Tsao; X Z Lin
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

Review 7.  Pathogenesis of Helicobacter pylori infection.

Authors:  Johannes G Kusters; Arnoud H M van Vliet; Ernst J Kuipers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

8.  cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia.

Authors:  N Broutet; A Marais; H Lamouliatte; A de Mascarel; R Samoyeau; R Salamon; F Mégraud
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

9.  Helicobacter pylori genotyping and sequencing using paraffin-embedded biopsies from residents of colombian areas with contrasting gastric cancer risks.

Authors:  Liviu A Sicinschi; Pelayo Correa; Richard M Peek; M Constanza Camargo; Alberto Delgado; M Blanca Piazuelo; Judith Romero-Gallo; Luis E Bravo; Barbara G Schneider
Journal:  Helicobacter       Date:  2008-04       Impact factor: 5.753

10.  Helicobacter pylori cag pathogenicity island's role in B7-H1 induction and immune evasion.

Authors:  Taslima T Lina; Shatha Alzahrani; Jennifer House; Yoshio Yamaoka; Arlene H Sharpe; Bill A Rampy; Irina V Pinchuk; Victor E Reyes
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.